Effectiveness of Snake Antivenom: Species and Regional Venom Variation and Its Clinical Impact

References

• Afifiyan F., Armugam A., Tan C. H., Gopalakrishnakone P., Jeyaseelan K. Postsynaptic alpha‐neurotoxin gene of the spitting cobra, Naja naja sputatrix: structure, organization, and phylogenetic analysis. Genome Res. Mar., 1999; 9(3)259–266
   PubMed Web of Science ®Google Scholar
• Assakura M. T., Furtado M. F.D., Mandelbaum F. R. Biochemical and biological differentiation of the venoms of the lancehead vipers (Bothrops atrox, Bothrops asper, Bothrops marajoensis and Bothrops moojeni). Comp. Biochem. Physiol., B, Comp. Chem. 1992; 102: 727–732
   Web of Science ®Google Scholar
• Barchan D., Kachalsky S., Neumann D., Vogel Z., Ovadia M., Kochva E., Fuchs S. How the mongoose can fight the snake: the binding site of the mongoose acetylcholine receptor. Proc. Natl. Acad. Sci. U. S. A. Aug. 15, 1992; 89(16)7717–7721
   PubMed Web of Science ®Google Scholar
• Barfaraz A., Harvey A. L. The use of the chick biventer cervicis preparation to assess the protective activity of six international reference antivenoms on the neuromuscular effects of snake venoms in vitro. Toxicon 1994; 32: 267–272
   PubMed Web of Science ®Google Scholar
• Brazil V. Contribuição ao estudo de veneno ophídico. III. Tratamentos das mordeduras das cobras. Rev. Med. (São Paulo) 1901; 4: 375–380
   Google Scholar
• Calmette A. Propriétés du sérum des animaux immunisés contre le venin des serpents; thérapeutique de l'envenimation. C. R. Hebd. Seances Acad. Sci., Paris 1894; 118: 720–722
   Google Scholar
• Calmette A. Venoms, Venomous Animals and Serotherapy. Masson, Paris 1908, (French Ed. 1907)
   Google Scholar
• Chang L., Lin S., Huang H., Hsiao M. Genetic organization of alpha‐bungarotoxins from Bungarus multicinctus (Taiwan banded krait): evidence showing that the production of alpha‐bungarotoxin isotoxins is not derived from edited mRNAs. Nucleic Acids Res. Oct. 15, 1999; 27(20)3970–3975
   PubMed Web of Science ®Google Scholar
• Cheng A. C., Winkel K. D. Call for global snakebite control and procurement funding. Lancet 2001a; 357: 1132
   PubMedGoogle Scholar
• Cheng A. C., Winkel K. D. Snakebite and antivenoms in the Asia‐Pacific: Wokabaut wantaim—raka hebou (“walking together”). Med. J. Aust. 2001b; 175: 648–651
   PubMed Web of Science ®Google Scholar
• Chippaux J.‐P. Snake bites: appraisal of the global situation. Bull. W.H.O. 1998; 76: 515–524
   PubMed Web of Science ®Google Scholar
• Chippaux J. P., Goyffon M. Venoms, antivenoms and immunotherapy. Toxicon 1998; 36: 823–846
   PubMed Web of Science ®Google Scholar
• Crachi M. T., Hammer L. W., Hodgson W. C. The effects of antivenom on the in vitro neurotoxicity of venoms from the taipans Oxyuranus scutellatus, Oxyuranus microlepidotus and Oxyuranus scutellatus canni. Toxicon 1999; 37: 1771–1778
   PubMed Web of Science ®Google Scholar
• Daltry J. C., Wüster W., Thorpe R. S. Diet and snake venom evolution. Nature 1996; 379: 537–540
   PubMed Web of Science ®Google Scholar
• Frazer T. R. The rendering of animals immune against the venom of the cobra and other serpents and the antidotal properties of the blood serum of immunised animals. Br. Med. J. 1895; 1: 1309–1312
   PubMedGoogle Scholar
• Fry B. G., Wickramaratna J. C., Jones A., Alewood P. F., Hodgson W. C. Species and regional variations in the effectiveness of antivenom against the in vitro neurotoxicity of death adder (Acanthophis) venoms. Toxicol. Appl. Pharmacol. 2001; 175: 140–148
   PubMed Web of Science ®Google Scholar
• Fry B. G., Wickramaratna J. C., Hodgson W. C., Alewood P. F., Kini R. M., Ho H., Wüster W. Electrospray liquid chromatography/mass spectrometry fingerprinting of Acanthophis (death adder) venoms: taxonomic and toxinological implications. Rapid Commun. Mass Spectrom. Mar. 30, 2002; 16(6)600–608
   PubMed Web of Science ®Google Scholar
• Galli R. The antivenin is safe, but its future is uncertain. West. J. Med. 2001; 175: 91–92
   PubMedGoogle Scholar
• Gillissen A., Theakston R. D., Barth J., May B., Krieg M., Warrell D. A. Neurotoxicity, haemostatic disturbances and haemolytic anaemia after a bite by a Tunisian saw‐scaled or carpet viper (Echis ‘pyramidum’‐complex): failure of antivenom treatment. Toxicon 1994; 32: 937–944
   PubMed Web of Science ®Google Scholar
• Glenn J. L., Straight R. C., Wolfe M. C., Hardy D. L. Geographical variation in Crotalus scutulatus scutulatus (Mojave rattlesnake) venom properties. Toxicon 1983; 21: 119–130
   PubMed Web of Science ®Google Scholar
• Gutiérrez J. M., Rojas G., Lomonte B., Gene J. A., Chaves F., Alvarado J., Rojas E. Standardization of assays for testing the neutralizing ability of antivenoms. Toxicon 1990; 28: 1127–1129
   PubMed Web of Science ®Google Scholar
• Hawgood B. Pioneers of antivenomous serotherapy: Dr. Vital Brazil (1865–1950). Toxicon 1992; 30: 573–579
   PubMed Web of Science ®Google Scholar
• Heatwole H., Poran N. S. Resistances of sympatric and allopatric eels to sea snake venoms. Copeia 1995; 1995: 136–147
   Google Scholar
• Henderson A., Baldwin L. N., May C. Fatal brown snake (Pseudonaja textilis) envenomation despite the use of antivenom. Med. J. Aust. 1993; 158: 709–710
   PubMed Web of Science ®Google Scholar
• Jiménez‐Porras J. M. Venom proteins of the fer‐de‐lance Bothrops atrox from Costa Rica. Toxicon 1964; 2: 155–166
   PubMedGoogle Scholar
• Kordiš D., Gubenšek F. Adaptive evolution of animal toxin multigene families. Gene 2000; 261: 43–52
   PubMed Web of Science ®Google Scholar
• Lamb G. On the serum therapeutics of cases of snake bite. Lancet 1904; ii: 1273–1277
   Google Scholar
• Looareesuwan S., Viravan C., Warrell D. A. Factors contributing to fatal snake bite in the tropics: analysis of 46 cases in Thailand. Trans. R. Soc. Trop. Med. Hyg. 1988; 82: 930–934
   PubMed Web of Science ®Google Scholar
• Martin C. J. The curative value of Calmette's antivenomous serum in the treatment of innoculations with the poisons of Australian snakes. Intercoloni. Med. J. Aust. 1897; 2: 527–536
   Google Scholar
• Masci P. P., Mirtschin P. J., Nias T. N., Turnbull R. K., Kuchel T. R., Whitaker A. N. Brown snakes (Pseudonaja genus): venom yields, prothrombin activator neutralisation and implications affecting antivenom usage. Anaesth. Intensive Care 1998; 26: 276–281
   PubMed Web of Science ®Google Scholar
• McNamee D. Tackling venomous snake bites worldwide. Lancet 2001; 357: 1680
   PubMed Web of Science ®Google Scholar
• Mebs D., Kornalík F. Schlangengiftseren—Probleme ihrer Wirksamkeit, untersucht am Beispiel von Echis carinatus. Salamandra 1981; 17: 89–98
   Google Scholar
• Phisalix C., Bertrand G. Sur la propriété antitoxique du sang des animaux vaccinés contre le venin de vipère. C. R. Soc. Biol. 1894; 46: 111–114
   Google Scholar
• Poran N. S., Coss R. G., Benjamini E. Resistance of California ground squirrels (Spermophilus beecheyi) to the venom of the northern Pacific rattlesnake (Crotalus viridis oreganus): a study of adaptive variation. Toxicon 1987; 25: 767–777
   PubMed Web of Science ®Google Scholar
• Russell F. E. Snake venom immunology: historical and practical considerations. J. Toxicol., Toxin Rev. 1988; 7: 1–82
   Web of Science ®Google Scholar
• Scholtz M. WHO's role in ensuring access to essential drugs. W.H.O. Drug Inf. 1999; 13: 217–220
   Google Scholar
• Sells P. G., Laing G. D., Theakston R. D.G. An in vivo but insensate model for the evaluation of antivenoms (ED50) using fertile hens' eggs. Toxicon 2001; 39: 665–668
   PubMed Web of Science ®Google Scholar
• Slowinski J. B., Knight A., Rooney A. P. Inferring species trees from gene trees: a phylogenetic analysis of the Elapids (Serpentes) based on amino acid sequences of venom proteins. Mol. Phylogenet. Evol. 1997; 8: 349–362
   PubMed Web of Science ®Google Scholar
• Sprivulus P., Jelinek G. A., Marshall I. Efficacy and potency of antivenoms in neutralising the procoagulant effects of Australian snake venoms in dog and human plasma. Anaesth. Intensive Care 1996; 24: 379–381
   PubMed Web of Science ®Google Scholar
• Sutherland S. K., Leonard R. Snake bite deaths in Australia 1992–1994 and a management update. Med. J. Aust. 1995; 163: 616–618
   PubMed Web of Science ®Google Scholar
• Sutherland S. K., Tibballs J. Chapter 7. Genus Pseudonaja, brown snakes. Australian animal toxins. The Creatures, Their Toxins and the Care of the Poisoned Patient. Oxford University Press, MelbourneAustralia 2001; 108
   Google Scholar
• Theakston R. D.G., Reid H. A. Development of simple standard assay procedures for the characterization of snake venoms. Bull. W.H.O. 1983; 61: 949–956
   PubMed Web of Science ®Google Scholar
• Theakston R. D.G., Warrell D. A. Crisis in snake antivenom supply for Africa. Lancet 2000; 356: 2104
   PubMed Web of Science ®Google Scholar
• Tibballs J., Sutherland S. K. The efficacy of antivenom in the prevention of cardiovascular depression and coagulopathy induced by brown snake (Pseudonaja) species venom. Anaesth. Intensive Care 1991; 19: 530–534
   PubMed Web of Science ®Google Scholar
• Tidswell F. A preliminary note on the serum‐therapy of snake bite. Australas. Med. Gaz. 1902; 21: 177–181
   Google Scholar
• Trevan J. W. The error of determination of toxicity. Proc. R. Soc. 1927; 101B: 483
   Google Scholar
• Trinca J. C. Report of recovery from a taipan bite. Med. J. Aust. 1969; 1: 514–516
   PubMed Web of Science ®Google Scholar
• Viravan C., Looareesuwan S., Kosakarn W., Wuthiekanun V., McCarthy C. J., Stimson A. F., Bunnag D., Harinasuta T., Warrell D. A. A national hospital‐based survey of snakes responsible for bites in Thailand. Trans. R. Soc. Trop. Med. Hyg. 1992; 86: 100–106
   PubMed Web of Science ®Google Scholar
• Vogtman D. B. The relative efficiency of two types of antivenom sera in neutralizing cobra venom. Copeia 1950; 1950: 225–228
   Google Scholar
• Warrell D. A. Tropical snake bite: clinical studies in south‐east Asia. Natural Toxins—Animal, Plant and Microbial, J. B. Harris. Clarendon Press, Oxford 1986; 25–45
   Google Scholar
• Warrell D. A. Snake venoms in science and clinical medicine 1. Russell's viper: biology, venom and treatment of bites. Trans. R. Soc. Trop. Med. Hyg. 1989; 83: 732–740
   PubMed Web of Science ®Google Scholar
• Warrell D. A. WHO/SEARO guidelines for the clinical management of snake bites in the Southeast Asian region. Southeast Asian J. Trop. Med. Public Health 1999; 30(Suppl. 1)1–85
   Google Scholar
• Warrell D. A., Arnett C. The importance of bites by the saw‐scaled or carpet viper (Echis carinatus): epidemiological studies in Nigeria and a review of the world literature. Acta Trop. 1976; 33: 307–341
   PubMedGoogle Scholar
• World Health Organization Publishing, Geneva. Progress in the Characterization of Venom and Standardization of Antivenoms. W.H.O. Offset Publ., 1981; 58, 44
   Google Scholar
• Wilkinson J. A., Glenn J. L., Straight R. C., Sites J. W., Jr. Distribution and genetic variation in venom A and venom B populations of the Mojave rattlesnake (Crotalus scutulatus scutulatus) in Arizona. Herpetologica 1991; 47: 54–68
   Web of Science ®Google Scholar
• Winkel K. D., Rinauldo M., Fry B. G., Hawdon G. M., Carroll T. Black snake, brown snake or mistake? A cautionary tale. Aust. Fam. Physician 2001; 30: 832
   PubMedGoogle Scholar
• Wüster W., McCarthy C. J. Venomous snake systematics: implications for snake bite treatment and toxinology. Envenomings and Their Treatments, C. Bon, M. Goyffon. Fondation Marcel Mérieux, Lyon 1996; 13–23
   Google Scholar
• Wüster W., Otsuka S., Malhotra A., Thorpe R. S. Population systematics of Russell's viper: a multivariate study. Biol. J. Linn. Soc. 1992; 47: 97–113
   Web of Science ®Google Scholar
• Yang C. C., Chang L. S., Wu F. S. Venom constituents of Notechis scutatus scutatus (Australian tiger snake) from differing geographic regions. Toxicon 1991; 29(11)1337–1344
   PubMed Web of Science ®Google Scholar